Cargando…

Intrahepatic vascular changes in non-alcoholic fatty liver disease: Potential role of insulin-resistance and endothelial dysfunction

Metabolic syndrome is a cluster of several clinical conditions characterized by insulin-resistance and high cardiovascular risk. Non-alcoholic fatty liver disease is the liver expression of the metabolic syndrome, and insulin resistance can be a frequent comorbidity in several chronic liver diseases...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pasarín, Marcos, Abraldes, Juan G, Liguori, Eleonora, Kok, Beverley, La Mura, Vincenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5645612/ https://www.ncbi.nlm.nih.gov/pubmed/29085222 http://dx.doi.org/10.3748/wjg.v23.i37.6777

Ejemplares similares

Sinusoidal Endothelial Dysfunction Precedes Inflammation and Fibrosis in a Model of NAFLD
por: Pasarín, Marcos, et al.
Publicado: (2012)

Contribution of Cyclooxygenase End Products and Oxidative Stress to Intrahepatic Endothelial Dysfunction in Early Non-Alcoholic Fatty Liver Disease
por: Gonzalez-Paredes, Francisco Javier, et al.
Publicado: (2016)

Coagulation, Microenvironment and Liver Fibrosis
por: Bitto, Niccolò, et al.
Publicado: (2018)

Non-alcoholic fatty liver disease may be associated with endothelial dysfunction
por: Balta, Sevket, et al.
Publicado: (2014)

Endothelial dysfunction and carotid atherosclerosis in non-alcoholic fatty liver disease
por: Dogru, Teoman, et al.
Publicado: (2014)

Study of Endothelial Dysfunction in Patients With Non-alcoholic Fatty Liver Disease
por: Jose, Nijin, et al.
Publicado: (2021)

Hypercoagulability in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD): Causes and Consequences
por: Tripodi, Armando, et al.
Publicado: (2022)

Serum levels of vascular endothelial growth factor in non-alcoholic fatty liver disease
por: Papageorgiou, Maria-Vasiliki, et al.
Publicado: (2017)

Effects of sitagliptin on intrahepatic lipid content in patients with non-alcoholic fatty liver disease
por: Wang, Xingchun, et al.
Publicado: (2022)

Protocol for measuring intrahepatic triglyceride content in adults with non-alcohol fatty liver disease
por: Ezpeleta, Mark, et al.
Publicado: (2023)

Plasma vascular endothelial growth factor B is elevated in non-alcoholic fatty liver disease patients and associated with blood pressure and renal dysfunction
por: Ye, Xiaofeng, et al.
Publicado: (2020)

Non-alcoholic fatty liver disease, vascular inflammation and insulin resistance are exacerbated by TRAIL deletion in mice
por: Cartland, Siân P., et al.
Publicado: (2017)

Intrahepatic vascular trauma
por: Harfouche, Melike, et al.
Publicado: (2021)

Postpartum Acute Liver Dysfunction: A Case of Acute Fatty Liver of Pregnancy Developing Massive Intrahepatic Calcification
por: Bhat, Khalid Javid, et al.
Publicado: (2015)

Additive Effect of Non-Alcoholic Fatty Liver Disease on Metabolic Syndrome-Related Endothelial Dysfunction in Hypertensive Patients
por: Perticone, Maria, et al.
Publicado: (2016)

Gut Dysfunction and Non-alcoholic Fatty Liver Disease
por: Grabherr, Felix, et al.
Publicado: (2019)

Establishment of Orthotopic Liver Tumors by Surgical Intrahepatic Tumor Injection in Mice with Underlying Non-Alcoholic Fatty Liver Disease
por: Brown, Zachary J., et al.
Publicado: (2018)

Multi-disciplinary clinic models for the management of non-alcoholic fatty liver disease
por: Zoncapè, Mirko, et al.
Publicado: (2022)

Causes of erectile dysfunction in non-alcoholic fatty liver disease
por: Tarik Kani, Haluk, et al.
Publicado: (2021)

The impact of periodontitis on vascular endothelial dysfunction
por: Li, Qian, et al.
Publicado: (2022)

Vascular stiffening and endothelial dysfunction in atherosclerosis
por: Hooglugt, Aukie, et al.
Publicado: (2022)

Novel insights into non-alcoholic fatty liver disease and dementia: insulin resistance, hyperammonemia, gut dysbiosis, vascular impairment, and inflammation
por: Cheon, So Yeong, et al.
Publicado: (2022)

Role of thiazolidinediones, insulin sensitizers, in non‐alcoholic fatty liver disease
por: Chang, Eugene, et al.
Publicado: (2013)

Nutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin Resistance
por: Yki-Järvinen, Hannele
Publicado: (2015)

Clinical and genetic determinants of the fatty liver–coagulation balance interplay in individuals with metabolic dysfunction
por: Valenti, Luca, et al.
Publicado: (2022)

Severe Intrahepatic Cholestasis Pregnancy Is Associated With Maternal Endothelial Dysfunction: A Case-Control Study
por: Kırlangıç, Mehmet Mete, et al.
Publicado: (2022)

Role of free fatty acids in endothelial dysfunction
por: Ghosh, Arijit, et al.
Publicado: (2017)

Fatty liver biomarkers and insulin resistance indices in the prediction of non‐alcoholic fatty liver disease in Ghanaian patients
por: Bockarie, A. S., et al.
Publicado: (2023)

“Non alcoholic fatty liver disease and eNOS dysfunction in humans”
por: Persico, Marcello, et al.
Publicado: (2017)

Tumor attachment to Major intrahepatic vascular for Colorectal liver metastases
por: Liu, Wei, et al.
Publicado: (2023)

Fatty acid-binding protein 4 impairs the insulin-dependent nitric oxide pathway in vascular endothelial cells
por: Aragonès, Gemma, et al.
Publicado: (2012)

Endothelial dysfunction in patients with non-alcoholic steatohepatitis
por: Onal, Ibrahim Koral
Publicado: (2014)

The Relationship between Insulin Resistance and Liver Damage in non-alcoholic Fatty Liver Patients
por: Cetin, Elif Guven, et al.
Publicado: (2020)

Vascular Inflammation and Endothelial Dysfunction in Experimental Hypertension
por: Savoia, Carmine, et al.
Publicado: (2011)

Vascular senescence in progeria: role of endothelial dysfunction
por: Xu, Qiu, et al.
Publicado: (2022)

Vascular Endothelial Regulation of Obesity-Associated Insulin Resistance
por: Li, Manna, et al.
Publicado: (2017)

APPL1 Counteracts Obesity-Induced Vascular Insulin Resistance and Endothelial Dysfunction by Modulating the Endothelial Production of Nitric Oxide and Endothelin-1 in Mice
por: Wang, Yi, et al.
Publicado: (2011)

Correction to: “Non alcoholic fatty liver disease and eNOS dysfunction in humans”
por: Persico, Marcello, et al.
Publicado: (2017)

Comparing the Mortality Risk between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease
por: Jung, Han Na, et al.
Publicado: (2023)

Gut–Liver Axis and Non-Alcoholic Fatty Liver Disease: A Vicious Circle of Dysfunctions Orchestrated by the Gut Microbiome
por: Pezzino, Salvatore, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e20ui9v9r8ci2ijcmb503609fq